Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It also provides SARS-COV-2(COVID-19) products that includes nucleic acid detection kit and other products; glucometers; POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR kit; and pathology products. The company was incorporated in 1994 and is based in Chengdu, China.
Maccura Biotechnology Dividend Announcement
• Maccura Biotechnology announced a annually dividend of ¥0.15 per ordinary share which will be made payable on 2024-07-03. Ex dividend date: 2024-07-03
• Maccura Biotechnology annual dividend for 2024 was ¥0.15
• Maccura Biotechnology annual dividend for 2023 was ¥0.35
• Maccura Biotechnology's trailing twelve-month (TTM) dividend yield is 1.1%
• Maccura Biotechnology's payout ratio for the trailing twelve months (TTM) is 99.16%
• Maccura Biotechnology's dividend growth over the last five years (2018-2023) was 20.67% year
Maccura Biotechnology Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-03 | ¥0.15 | annually | 2024-07-03 |
2023-05-29 | ¥0.35 | annually | 2023-05-29 |
2022-05-19 | ¥0.47 | annually | 2022-05-19 |
2021-06-01 | ¥0.43 | annually | 2021-06-01 |
2020-06-17 | ¥0.19 | annually | 2020-06-17 |
2019-07-02 | ¥0.16 | annually | 2019-07-02 |
2018-05-29 | ¥0.14 | annually | 2018-05-29 |
2017-05-31 | ¥0.11 | annually | 2017-05-31 |
2016-06-08 | ¥0.27 | annually |
Maccura Biotechnology Dividend per year
Maccura Biotechnology Dividend growth
Maccura Biotechnology Dividend Yield
Maccura Biotechnology current trailing twelve-month (TTM) dividend yield is 1.1%. Interested in purchasing Maccura Biotechnology stock? Use our calculator to estimate your expected dividend yield:
Maccura Biotechnology Financial Ratios
Maccura Biotechnology Dividend FAQ
Other factors to consider when evaluating Maccura Biotechnology as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Maccura Biotechnology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Maccura Biotechnology's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Maccura Biotechnology publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Maccura Biotechnology distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Maccura Biotechnology are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Maccura Biotechnology sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Maccura Biotechnology distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Maccura Biotechnology declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Maccura Biotechnology's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Maccura Biotechnology's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.